M Bergouignan|A Seilhean|P Henry - JoVE Visualize

Showing results (451-460 of 782) with videos related to

Pageof 79

Sort By:

Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 1998

Pharmacokinetics of an antisense oligonucleotide injected intravitreally in monkeysJ M Leeds, S P Henry, S Bistner, et al.

Hormones and Behavior|September 6, 2001

Neuroendocrine and behavioral implications of endocrine disrupting chemicals in quailM A Ottinger, M A Abdelnabi, P Henry, et al.

Journal of Inorganic Biochemistry|August 26, 2011

Iron binding of 3-hydroxychromone, 5-hydroxychromone, and sulfonated morin: Implications for the antioxidant activity of flavonols with competing metal binding sitesAndrea M Verdan, Hsiao C Wang, Carla R García, et al.

Revue Neurologique|December 1, 1976

[Evolutive aspects of cerebral vascular complications. Tomodensitometric study]J M Caillé, P Constant, A Dop, et al.

Cephalalgia : an International Journal of Headache|January 22, 2005

Variability of reported headache symptoms and diagnosis of migraine at 12 monthsF Nachit-Ouinekh, V Chrysostome, P Henry, et al.

Toxicology|January 15, 1997

Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley ratsS P Henry, L R Grillone, J L Orr, et al.

Ugeskrift for Laeger|November 4, 1996

[The combination of oral lysine-acetylsalicylate and metoclopramide compared with oral sumatriptan in the treatment of migraine attacks. A randomized, double-blind, placebo-controlled clinical trial]P Tfelt-Hansen, P Henry, L J Mulder, et al.

Journal of Neurochemistry|August 29, 1998

Regulation of the Ca2+ sensitivity of exocytosis by Rab3aL Johannes, P M Lledo, P Chameau, et al.

Cancer Research|June 11, 1998

Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cellsX Y Sun, C A Plouzek, J P Henry, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 1, 1997

Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbitJ M Leeds, S P Henry, L Truong, et al.

Pageof 79

Showing results (451-460 of 782) with videos related to

Sort By:

Pageof 79

Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 1998

Pharmacokinetics of an antisense oligonucleotide injected intravitreally in monkeysJ M Leeds, S P Henry, S Bistner, et al.

Hormones and Behavior|September 6, 2001

Neuroendocrine and behavioral implications of endocrine disrupting chemicals in quailM A Ottinger, M A Abdelnabi, P Henry, et al.

Journal of Inorganic Biochemistry|August 26, 2011

Iron binding of 3-hydroxychromone, 5-hydroxychromone, and sulfonated morin: Implications for the antioxidant activity of flavonols with competing metal binding sitesAndrea M Verdan, Hsiao C Wang, Carla R García, et al.

Revue Neurologique|December 1, 1976

[Evolutive aspects of cerebral vascular complications. Tomodensitometric study]J M Caillé, P Constant, A Dop, et al.

Cephalalgia : an International Journal of Headache|January 22, 2005

Variability of reported headache symptoms and diagnosis of migraine at 12 monthsF Nachit-Ouinekh, V Chrysostome, P Henry, et al.

Toxicology|January 15, 1997

Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley ratsS P Henry, L R Grillone, J L Orr, et al.

Ugeskrift for Laeger|November 4, 1996

[The combination of oral lysine-acetylsalicylate and metoclopramide compared with oral sumatriptan in the treatment of migraine attacks. A randomized, double-blind, placebo-controlled clinical trial]P Tfelt-Hansen, P Henry, L J Mulder, et al.

Journal of Neurochemistry|August 29, 1998

Regulation of the Ca2+ sensitivity of exocytosis by Rab3aL Johannes, P M Lledo, P Chameau, et al.

Cancer Research|June 11, 1998

Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cellsX Y Sun, C A Plouzek, J P Henry, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 1, 1997

Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbitJ M Leeds, S P Henry, L Truong, et al.

Pageof 79